Sarcoidosis Clinical Trials

Find Sarcoidosis Clinical Trials Near You

A Prospective Diagnostic Trial of Al[¹⁸F]F-NOTA-folate PET in Patients With Suspected Cardiac Sarcoidosis and Infective Endocarditis (FOL-CARD)

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this prospective diagnostic study is to evaluate the imaging characteristics, diagnostic performance, radiation dosimetry, and safety of Al\[¹⁸F\]F-NOTA-folate PET imaging in patients with suspected cardiac sarcoidosis and infective endocarditis, and healthy volunteers. The study is non-interventional with respect to clinical management, and all diagnostic and therapeutic decisions are made according to routine clinical practice independent of study participation. The main aims are to evaluate quantitative uptake of Al\[¹⁸F\]F-NOTA-folate measured by PET imaging in the left ventricular myocardium of patients with suspected cardiac sarcoidosis, and in cardiac valves or prosthetic valve regions in patients with suspected infective endocarditis. Participants will undergo PET imaging with Al\[¹⁸F\]F-NOTA-folate tracer at the Turku PET Centre. Participants with suspected cardiac sarcoidosis will undergo a second PET imaging study after initiation of immunosuppressive therapy.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• Ability to provide written informed consent

• Suspected cardiac sarcoidosis group: clinical suspicion of cardiac sarcoidosis requiring diagnostic evaluation, including cardiac magnetic resonance and/or \[¹⁸F\]FDG PET

• Suspected infective endocarditis group: clinical suspicion of native or prosthetic valve infective endocarditis requiring diagnostic evaluation

• Healthy volunteers group:

• Age above 50 and post-menopausal (women)

• No history of cardiovascular disease, systemic inflammatory disease, malignancy, and no active infection

Locations
Other Locations
Finland
Turku University Hospital
RECRUITING
Turku
Contact Information
Primary
Antti Saraste, Professor
antti.saraste@utu.fi
00358 50 4499979
Backup
Tuija Vasankari, MSc
tuija.vasankari@varha.fi
Time Frame
Start Date: 2026-09-14
Estimated Completion Date: 2030-12-31
Participants
Target number of participants: 143
Treatments
Experimental: Suspected cardiac sarcoidosis
Patients with suspected cardiac sarcoidosis. All diagnostic and therapeutic decisions are made according to routine clinical practice independent of study participation.
Experimental: Suspected infective endocarditis
Patients with suspected infective endocarditis. All diagnostic and therapeutic decisions are made according to routine clinical practice independent of study participation.
Experimental: Healthy volunteers
Healthy volunteers without known cardiovascular or systemic inflammatory disease.
Sponsors
Collaborators: Satasairaala, Helsinki University Central Hospital
Leads: Turku University Hospital

This content was sourced from clinicaltrials.gov

Similar Clinical Trials